Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Richard S Ungerleider, MD
Theradex
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Birmingham Hematology & Oncology
Birmingham, Alabama, United States
- Hematology Oncology Associates
Phoenix, Arizona, United States
- Alta Bates Medical Center - Comprehensive Cancer Center
Berkeley, California, United States
- Moores Ucsd Cancer Center
La Jolla, California, United States
- Rocky Mountain Cancer Center - Denver
Denver, Colorado, United States
- Rocky Mountain Cancer Center - Sky Ridge
Lone Tree, Colorado, United States
- Ocala Oncology Center
Ocala, Florida, United States
- Cancer Centers of Florida, Pa
Ocoee, Florida, United States
- John B. Amos Cancer Center
Columbus, Georgia, United States
- Cancer Care & Hematology Specialists of Chicago
Niles, Illinois, United States
- Oncology & Hematology of Central Illinois
Peoria, Illinois, United States
- Blessing Cancer Center
Quincy, Illinois, United States
- Central Indiana Cancer Centers
Indianapolis, Indiana, United States
- Hope Center
Terre Haute, Indiana, United States
- Norton Healthcare - Louisville Oncology
Louisville, Kentucky, United States
- Johns Hopkins Hospital - the Bunting Blaustein Cancer Research Building
Baltimore, Maryland, United States
- Sinai Hospital of Baltimore
Baltimore, Maryland, United States
- Maryland Oncology Hematology, Pa
Columbia, Maryland, United States
- Alliance Hematology Oncology, Pa - Carroll County Cancer Center
Westminster, Maryland, United States
- Minnesota Oncology Hematology, Pa
Minneapolis, Minnesota, United States
- Missouri Cancer Associates
Columbia, Missouri, United States
- St. Joseph Oncology, Inc.
Saint Joseph, Missouri, United States
- Arch Medical Services - Center for Cancer Care & Research
St Louis, Missouri, United States
- Hematology/oncology Consultants
St Louis, Missouri, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- New York Oncology Hematology, Pc
Albany, New York, United States
- Suny Upstate Medical University - Regional Oncology Center
Syracuse, New York, United States
- Northwestern Carolina Oncology & Hematology
Hickory, North Carolina, United States
- Cancer Centers of North Carolina
Raleigh, North Carolina, United States
- Willamette Valley Cancer Center
Eugene, Oregon, United States
- Northwest Cancer Specialists
Portland, Oregon, United States
- Medical Oncology Associates
Kingston, Pennsylvania, United States
- Cancer Centers of the Carolinas
Greenville, South Carolina, United States
- Texas Oncology Cancer Center
Austin, Texas, United States
- Texas Cancer Center at Medical City
Dallas, Texas, United States
- Texas Oncology - Sammons Cancer Center
Dallas, Texas, United States
- Texas Oncology, Pa
Dallas, Texas, United States
- Texas Oncology, Pa
Fort Worth, Texas, United States
- Alison Cancer Center
Midland, Texas, United States
- West Texas Cancer Center
Odessa, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2006
- Primary completion
- 31 Jul 2008
- Completion
- 31 Jan 2009
- Last update posted
- 30 Sept 2009
- Registered enrollment
- 76
- Registry id
- NCT00319969
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.